

Author: Manicourt Daniel-Henri Bevilacqua Maurizio
Publisher: Adis International
ISSN: 1174-5886
Source: Drugs in R&D, Vol.6, Iss.5, 2005-01, pp. : 261-271
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Zoledronic acid: Flare-up of osteoarthritis: case report
Reactions Weekly, Vol. 1, Iss. 1323, 2010-01 ,pp. :






Silibinin reduces serum ferritin levels in patients with chronic hepatitis C
Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. :